Use of thiopurines in inflammatory bowel disease

被引:1
|
作者
Pascal Frei [1 ]
Luc Biedermann [1 ]
Ole Haagen Nielsen [2 ]
Gerhard Rogler [1 ]
机构
[1] Division of Gastroenterology and Hepatology,Department of Internal Medicine,University Hospital of Zürich,CH-8091 Zürich,Switzerland
[2] Department of Gastroenterology,Medical Section,Herlev Hospital,University of Copenhagen,DK-2730 Herlev,Denmark
关键词
Thiopurines; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Immunosuppression; Infection;
D O I
暂无
中图分类号
R574 [肠疾病];
学科分类号
1002 ; 100201 ;
摘要
The use of thiopurines as immunosuppression for the treatment of refractory or chronic active inflammatory bowel disease is established for both Crohn’s disease and ulcerative colitis.Nevertheless,many questions remain concerning the optimal treatment regimens of azathioprine,6-mercaptopurine and thioguanine.We will briefly summarize dose recommendations,indications for thiopurine therapy and side effects which are relevant in clinical practice.We discuss some currently debated topics,including the combination of azathioprine and allopurinol,switching of thiopurine therapy in case of side effects,the use of azathioprine in pregnancy,the infection risk using thiopurines and the evidence when to stop thiopurines.Excellent reviews have been published on the thiopurine metabolic pathway which will not be discussed here in detail.
引用
收藏
页码:1040 / 1048
页数:9
相关论文
共 50 条
  • [41] Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease
    Marshall, John K.
    Otley, Anthony R.
    Afif, Waqqas
    Bernstein, Charles N.
    Hookey, Lawrence
    Leontiadis, Grigorios
    Panaccione, Remo
    Bressler, Brian
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 28 (07): : 371 - 372
  • [42] Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased
    van Schaik, Fiona D. M.
    van Oijen, Martijn G. H.
    Smeets, Hugo M.
    van der Heijden, Geert J. M. G.
    Siersema, Peter D.
    Oldenburg, Bas
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (05) : 449 - 450
  • [43] Thiopurines Prevent Advanced Colorectal Neoplasia in Patients With Inflammatory Bowel Disease
    van Schaik, Fiona D.
    Smeets, Hugo M.
    van der Heijden, Geert J.
    Siersema, Peter D.
    van Oijen, Martijn G.
    Oldenburg, Bas
    GASTROENTEROLOGY, 2011, 140 (05) : S42 - S43
  • [44] Relapse rates after withdrawal of thiopurines in patients with Inflammatory Bowel Disease
    Ranjan, M. K.
    Vuyyuru, S. K.
    Kante, B.
    Kumar, P.
    Mundhra, S. K.
    Golla, R.
    Sharma, R.
    Sahni, P.
    Das, P.
    Makharia, G.
    Kedia, S.
    Ahuja, V.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I330 - I331
  • [45] Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease
    Laharie, D.
    Riviere, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (05) : 689 - 690
  • [46] Toxicity of thiopurines in patients with inflammatory bowel disease: Frequency and risk factors
    Ben Mustapha, N.
    Labidi, A.
    Serghini, M.
    Fekih, M.
    Boubaker, J.
    Filali, A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S194 - S194
  • [47] Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)
    Lee, Kang-Moon
    Kim, You Sun
    Seo, Geom Seog
    Kim, Tae Oh
    Yang, Suk-Kyun
    INTESTINAL RESEARCH, 2015, 13 (03) : 193 - 207
  • [48] Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients
    Gazouli, M.
    Pachoula, I.
    Panayotou, I.
    Mantzaris, G.
    Syriopoulou, V. P.
    Goutas, N.
    Vlachodimitropoulos, D.
    Anagnou, N. P.
    Roma-Giannikou, E.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (01) : 93 - 97
  • [49] Toxicity of thiopurines in patients with inflammatory bowel disease: inventory and predictive factors
    Labidi, A.
    Serghini, M.
    Ben Mustapha, N.
    Fekih, M.
    Boubaker, J.
    Filali, A.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S283 - S283
  • [50] Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease
    Mukesh Kumar Ranjan
    Sudheer Kumar Vuyyuru
    Bhaskar Kante
    Peeyush Kumar
    Sandeep K. Mundhra
    Rithvik Golla
    Raju Sharma
    Peush Sahni
    Prasenjit Das
    Govind Makharia
    Saurabh Kedia
    Vineet Ahuja
    International Journal of Colorectal Disease, 2022, 37 : 1817 - 1826